http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004010937-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f477632f64551f9c076114eca6a134e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7e00c1be62e305d2c911b2ba205a017
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
filingDate 2003-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6f85d6869ebebde69ac62efec2f5dec
publicationDate 2004-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004010937-A3
titleOfInvention Method of treating cancer
abstract Methods for treating cancer are described herein. The methods include administering to an HIV-negative patient an m-calpain inhibitor such as ritonavir. Ritonavir or other m-calpain inhibitors can also be co-administered with other therapeutic agents such as a Cox-2 inhibitor, a taxane, or a proteasome inhibitor. Methods for determining whether a patient will respond to a particular method of treatment are also described herein.
priorityDate 2002-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6294518-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP43367
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ92178
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID392622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505741
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398153
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GLG1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27971
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ07009
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO08529
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP17655

Total number of triples: 36.